M. Ukkonen

530 total citations
15 papers, 413 citations indexed

About

M. Ukkonen is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, M. Ukkonen has authored 15 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 6 papers in Neurology and 5 papers in Oncology. Recurrent topics in M. Ukkonen's work include Multiple Sclerosis Research Studies (14 papers), Peripheral Neuropathies and Disorders (4 papers) and Immunotherapy and Immune Responses (4 papers). M. Ukkonen is often cited by papers focused on Multiple Sclerosis Research Studies (14 papers), Peripheral Neuropathies and Disorders (4 papers) and Immunotherapy and Immune Responses (4 papers). M. Ukkonen collaborates with scholars based in Finland, Slovakia and Austria. M. Ukkonen's co-authors include Irina Elovaara, Prasun Dastidar, Terho Lehtimäki, Mari Luomala, Jukka Peltola, T. Koivula, Mikko Hurme, Teuvo L.J. Tammela, T. Heinonen and E. M. Laasonen and has published in prestigious journals such as Neurology, Journal of the Neurological Sciences and Journal of Neurology.

In The Last Decade

M. Ukkonen

15 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Ukkonen Finland	13	274	153	111	82	78	15	413
Steffen Pfeuffer Germany	15	360 1.3×	176 1.2×	79 0.7×	154 1.9×	144 1.8×	53	588
Takeshi Kezuka Japan	14	153 0.6×	111 0.7×	124 1.1×	124 1.5×	42 0.5×	20	495
César Álvarez-González United Kingdom	9	258 0.9×	144 0.9×	37 0.3×	105 1.3×	148 1.9×	14	442
Daniel Rosenberg United States	5	171 0.6×	227 1.5×	58 0.5×	48 0.6×	50 0.6×	9	532
Aidan Droogan United Kingdom	14	291 1.1×	178 1.2×	83 0.7×	60 0.7×	81 1.0×	21	535
Mahtab Ghadiri Australia	7	262 1.0×	72 0.5×	106 1.0×	195 2.4×	42 0.5×	9	352
Paola Valentino Italy	12	314 1.1×	146 1.0×	103 0.9×	145 1.8×	105 1.3×	26	490
Roos M. van der Vuurst de Vries Netherlands	10	321 1.2×	152 1.0×	74 0.7×	140 1.7×	76 1.0×	14	493
Laura Bau Spain	11	315 1.1×	64 0.4×	96 0.9×	143 1.7×	61 0.8×	24	405
J. C. Alvarez‐Cermeño Spain	12	391 1.4×	119 0.8×	127 1.1×	262 3.2×	108 1.4×	20	529

Countries citing papers authored by M. Ukkonen

Since Specialization

Citations

This map shows the geographic impact of M. Ukkonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Ukkonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Ukkonen more than expected).

Fields of papers citing papers by M. Ukkonen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Ukkonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Ukkonen. The network helps show where M. Ukkonen may publish in the future.

Co-authorship network of co-authors of M. Ukkonen

This figure shows the co-authorship network connecting the top 25 collaborators of M. Ukkonen. A scholar is included among the top collaborators of M. Ukkonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Ukkonen. M. Ukkonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Seppä, Juha, M. Ukkonen, Auli Verkkoniemi‐Ahola, et al.. (2021). Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patients. Journal of Neurology. 269(2). 824–835. 9 indexed citations

Ukkonen, M., et al.. (2009). Cognitive dysfunction in primary progressive multiple sclerosis: a neuropsychological and MRI study. Multiple Sclerosis Journal. 15(9). 1055–1061. 16 indexed citations

Wu, Xingchen, Hanna Kuusisto, Prasun Dastidar, et al.. (2007). Once-weekly 22?g subcutaneous IFN-?-1a in secondary progressive MS: a 3-year follow-up study on brain MRI measurements and serum MMP-9 levels. Acta Neurologica Scandinavica. 116(1). 43–48. 3 indexed citations

Ukkonen, M., Xingchen Wu, Birgit M. Reipert, Prasun Dastidar, & Irina Elovaara. (2007). Cell surface adhesion molecules and cytokine profiles in primary progressive multiple sclerosis. Multiple Sclerosis Journal. 13(6). 701–707. 22 indexed citations

Wu, Xingchen, Prasun Dastidar, Hanna Kuusisto, et al.. (2005). Increased disability and MRI lesions after discontinuation of IFN-beta-1a in secondary progressive MS. Acta Neurologica Scandinavica. 112(4). 242–247. 14 indexed citations

Luomala, Mari, Terho Lehtimäki, Heini Huhtala, et al.. (2003). Promoter polymorphism of IL-10 and severity of multiple sclerosis. Acta Neurologica Scandinavica. 108(6). 396–400. 53 indexed citations

Ukkonen, M., Prasun Dastidar, T. Heinonen, E. M. Laasonen, & Irina Elovaara. (2003). Volumetric quantitation by MRI in primary progressive multiple sclerosis: volumes of plaques and atrophy correlated with neurological disability. European Journal of Neurology. 10(6). 663–669. 16 indexed citations

Ukkonen, M., Irina Elovaara, Prasun Dastidar, & Teuvo L.J. Tammela. (2003). Urodynamic findings in primary progressive multiple sclerosis are associated with increased volumes of plaques and atrophy in the central nervous system. Acta Neurologica Scandinavica. 109(2). 100–105. 43 indexed citations

Jalonen, Tuula O., et al.. (2002). Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes. Journal of Neurology. 249(5). 576–583. 33 indexed citations

10.

Luomala, Mari, Terho Lehtimäki, Irina Elovaara, et al.. (2001). A study of interleukin-1 cluster genes in susceptibility to and severity of multiple sclerosis. Journal of the Neurological Sciences. 185(2). 123–127. 36 indexed citations

11.

Peltola, Jukka, M. Ukkonen, Eeva Moilanen, & Irina Elovaara. (2001). Increased nitric oxide products in CSF in primary progressive MS may reflect brain atrophy. Neurology. 57(5). 895–896. 23 indexed citations

12.

Luomala, Mari, Irina Elovaara, M. Ukkonen, T. Koivula, & Terho Lehtimäki. (2001). The combination of HLA-DR1 and HLA-DR53 protects against MS. Neurology. 56(3). 383–385. 22 indexed citations

13.

Elovaara, Irina, M. Ukkonen, Terho Lehtimäki, et al.. (2000). Adhesion Molecules in Multiple Sclerosis. Archives of Neurology. 57(4). 546–546. 60 indexed citations

14.

Luomala, Mari, Irina Elovaara, M. Ukkonen, T. Koivula, & Terho Lehtimäki. (2000). Plasminogen activator inhibitor 1 gene and risk of MS in women. Neurology. 54(9). 1862–1864. 16 indexed citations

15.

Dastidar, Prasun, T. Heinonen, Terho Lehtimäki, et al.. (1999). Volumes of brain atrophy and plaques correlated with neurological disability in secondary progressive multiple sclerosis. Journal of the Neurological Sciences. 165(1). 36–42. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact